首页 > 最新文献

Arthroscopy-The Journal of Arthroscopic and Related Surgery最新文献

英文 中文
Podium Presentation Title: Lower Trapezius Tendon Transfer for Massive, Irreparable Rotator Cuff Tears
IF 4.4 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-02-01 DOI: 10.1016/j.arthro.2024.11.034
Jarret Woodmass M.D., F.R.C.S.C., Sheila McRae Ph.D., Hayden Cooke B.Sc., Anthony Karzon M.D., Peter Macdonald M.D., Michael Gottschalk M.D., Eric Wagner M.D.
{"title":"Podium Presentation Title: Lower Trapezius Tendon Transfer for Massive, Irreparable Rotator Cuff Tears","authors":"Jarret Woodmass M.D., F.R.C.S.C., Sheila McRae Ph.D., Hayden Cooke B.Sc., Anthony Karzon M.D., Peter Macdonald M.D., Michael Gottschalk M.D., Eric Wagner M.D.","doi":"10.1016/j.arthro.2024.11.034","DOIUrl":"10.1016/j.arthro.2024.11.034","url":null,"abstract":"","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":"41 2","pages":"Pages e15-e16"},"PeriodicalIF":4.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143153283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Podium Presentation Title: Biceps “Smash” Augmentation for Rotator Cuff Repair: Histological Analysis of Tenocyte Viability
IF 4.4 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-02-01 DOI: 10.1016/j.arthro.2024.11.033
Joseph Brinkman M.D., Gregory P. Colbath M.D., Patrick J. Denard M.D., Jeremy J. Mercuri Ph.D., Justin Makovicka M.D., John M. Tokish M.D.
{"title":"Podium Presentation Title: Biceps “Smash” Augmentation for Rotator Cuff Repair: Histological Analysis of Tenocyte Viability","authors":"Joseph Brinkman M.D., Gregory P. Colbath M.D., Patrick J. Denard M.D., Jeremy J. Mercuri Ph.D., Justin Makovicka M.D., John M. Tokish M.D.","doi":"10.1016/j.arthro.2024.11.033","DOIUrl":"10.1016/j.arthro.2024.11.033","url":null,"abstract":"","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":"41 2","pages":"Page e15"},"PeriodicalIF":4.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143153476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Root Repair Has Superior Radiological and Clinical Outcomes Than Partial Meniscectomy and Nonoperative Treatment in the Management of Meniscus Root Tears: A Systematic Review 在半月板根部撕裂的治疗中,根部修复术的放射学和临床效果优于半月板部分切除术和非手术治疗:系统回顾。
IF 4.4 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-02-01 DOI: 10.1016/j.arthro.2024.02.017
Dustin R. Lee M.D., Yining Lu M.D., Anna K. Reinholz B.S., Sara E. Till M.S., Abhinav Lamba B.S., Daniel B.F. Saris M.D., Ph.D., Christopher L. Camp M.D., Aaron J. Krych M.D.

Purpose

To compile and analyze structural and clinical outcomes after meniscus root tear treatment as currently described in the literature.

Methods

A review was conducted to identify studies published since 2011 on efficacy of repair, meniscectomy, and nonoperative management in the treatment of meniscus root tears. Patient cohorts were grouped into treatment categories, with medial and lateral root tears analyzed separately; data were collected on patient demographics, structural outcomes including joint space width, degree of medial meniscal extrusion, progression to total knee arthroplasty, and patient-reported outcome measures. Risk of bias was assessed using the MINORS (methodological index for non-randomized studies) criteria. Heterogeneity was measured using the I-statistic, and outcomes were summarized using forest plots without pooled means.

Results

The 56 included studies comprised a total of 3,191 patients. Mean age among the included studies ranged from 24.6 to 65.6 years, whereas mean follow-up ranged from 12 to 125.9 months. Heterogeneity analysis identified significant differences between studies. Change in joint space width ranged from –2.4 to –0.6 mm (i.e., decreased space) after meniscectomy (n = 186) and –0.9 to –0.1 mm after root repair (n = 209); change in medial meniscal extrusion ranged from –0.6 to 6.5 mm after root repair (n = 521) and 0.2 to 4.2 mm after meniscectomy (n = 66); and event rate for total knee arthroplasty ranged from 0.00 to 0.22 after root repair (n = 205), 0.35 to 0.60 after meniscectomy (n = 53), and 0.27 to 0.35 after nonoperative treatment (n = 93). Root repair produced the greatest numerical increase in International Knee Documentation Committee and Lysholm scores of the 3 treatment arms. In addition, root repair improvements in Knee Injury and Osteoarthritis Outcome Score Pain (range: 22-32), Sports and Recreational Activities (range: 23-36), Quality of Life (range: 22-42), and Symptoms subscales (range: 10-19), in studies with low risk of bias.

Conclusions

The literature reporting on the treatment of meniscus root tears is heterogenous and largely limited to Level III and IV studies. Current evidence suggests root repair may be the most effective treatment strategy in lessening joint space narrowing of the knee and producing improvements in patient-reported outcomes.

Level of Evidence

Level IV, systematic review of Level II-IV studies.
目的:本研究旨在整理和分析目前文献中描述的半月板根撕裂(MRT)治疗后的结构和临床效果:对 2011 年以来发表的有关半月板根部撕裂的修复、半月板切除和非手术治疗效果的研究进行了回顾。将患者队列按治疗类别分组,分别分析内侧和外侧半月板根撕裂;收集患者人口统计学、结构性结果(包括关节间隙宽度(JSW)、内侧半月板挤压程度(MME))、全膝关节置换术(TKA)进展以及患者报告结果指标(PROMs)等方面的数据。偏倚风险(ROB)采用 MINORS 标准进行评估。异质性采用 I 统计量进行衡量,结果采用森林图进行总结,不采用汇总平均值:结果:共纳入 56 项研究,3,191 名患者。纳入研究的平均年龄从 24.6 岁到 65.6 岁不等,平均随访时间从 12 个月到 125.9 个月不等。异质性分析发现不同研究之间存在显著差异。半月板切除术后,JSW的变化范围为-2.4 - -0.6毫米(即、半月板切除术后的 JSW 变化范围为 -2.4 - -0.6mm(即空间减少)(n=186),根部修复术后的 JSW 变化范围为 -0.90 - -0.1mm(n=209);根部修复术后的 MME 变化范围为 -0.6 - 6.5mm(n=521),半月板切除术后的 MME 变化范围为 0.2 - 4.半月板切除术后的 MME 变化范围为 0.2 - 4.2 毫米(n=66);根部修复术后的 TKA 事件率为 0.00 - 0.22(n=205),半月板切除术后为 0.35 - 0.60(n=53),非手术治疗后为 0.27 - 0.35(n=93)。在三种治疗方法中,根修复术使 IKDC 和 Lysholm 评分的数值增幅最大。此外,在ROB较低的研究中,根修复术对KOOS疼痛(范围:22 - 32)、运动和娱乐活动(范围:23 - 36)、生活质量(范围:22 - 42)和症状分量表(范围:10 - 19)均有改善:有关 MRT 治疗的文献报道不尽相同,大部分仅限于 III 级和 IV 级研究。目前的证据表明,根部修复可能是最有效的治疗策略,可减轻膝关节间隙狭窄,并改善患者报告的结果。
{"title":"Root Repair Has Superior Radiological and Clinical Outcomes Than Partial Meniscectomy and Nonoperative Treatment in the Management of Meniscus Root Tears: A Systematic Review","authors":"Dustin R. Lee M.D.,&nbsp;Yining Lu M.D.,&nbsp;Anna K. Reinholz B.S.,&nbsp;Sara E. Till M.S.,&nbsp;Abhinav Lamba B.S.,&nbsp;Daniel B.F. Saris M.D., Ph.D.,&nbsp;Christopher L. Camp M.D.,&nbsp;Aaron J. Krych M.D.","doi":"10.1016/j.arthro.2024.02.017","DOIUrl":"10.1016/j.arthro.2024.02.017","url":null,"abstract":"<div><h3>Purpose</h3><div>To compile and analyze structural and clinical outcomes after meniscus root tear treatment as currently described in the literature.</div></div><div><h3>Methods</h3><div>A review was conducted to identify studies published since 2011 on efficacy of repair, meniscectomy, and nonoperative management in the treatment of meniscus root tears. Patient cohorts were grouped into treatment categories, with medial and lateral root tears analyzed separately; data were collected on patient demographics, structural outcomes including joint space width, degree of medial meniscal extrusion, progression to total knee arthroplasty, and patient-reported outcome measures. Risk of bias was assessed using the MINORS (methodological index for non-randomized studies) criteria. Heterogeneity was measured using the I-statistic, and outcomes were summarized using forest plots without pooled means.</div></div><div><h3>Results</h3><div>The 56 included studies comprised a total of 3,191 patients. Mean age among the included studies ranged from 24.6 to 65.6 years, whereas mean follow-up ranged from 12 to 125.9 months. Heterogeneity analysis identified significant differences between studies. Change in joint space width ranged from –2.4 to –0.6 mm (i.e., decreased space) after meniscectomy (n = 186) and –0.9 to –0.1 mm after root repair (n = 209); change in medial meniscal extrusion ranged from –0.6 to 6.5 mm after root repair (n = 521) and 0.2 to 4.2 mm after meniscectomy (n = 66); and event rate for total knee arthroplasty ranged from 0.00 to 0.22 after root repair (n = 205), 0.35 to 0.60 after meniscectomy (n = 53), and 0.27 to 0.35 after nonoperative treatment (n = 93). Root repair produced the greatest numerical increase in International Knee Documentation Committee and Lysholm scores of the 3 treatment arms. In addition, root repair improvements in Knee Injury and Osteoarthritis Outcome Score Pain (range: 22-32), Sports and Recreational Activities (range: 23-36), Quality of Life (range: 22-42), and Symptoms subscales (range: 10-19), in studies with low risk of bias.</div></div><div><h3>Conclusions</h3><div>The literature reporting on the treatment of meniscus root tears is heterogenous and largely limited to Level III and IV studies. Current evidence suggests root repair may be the most effective treatment strategy in lessening joint space narrowing of the knee and producing improvements in patient-reported outcomes.</div></div><div><h3>Level of Evidence</h3><div>Level IV, systematic review of Level II-IV studies.</div></div>","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":"41 2","pages":"Pages 390-417"},"PeriodicalIF":4.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139944725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Micro-Fragmented Adipose Tissue Demonstrates Comparable Clinical Efficacy to Other Orthobiologic Injections in Treating Symptomatic Knee Osteoarthritis: A Systematic Review of Level I to IV Clinical Studies 微碎屑脂肪组织在治疗症状性膝骨关节炎方面的临床疗效与其他矫形生物注射剂相当。I-IV级临床研究的系统回顾。
IF 4.4 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-02-01 DOI: 10.1016/j.arthro.2024.03.002
Erik Hohmann M.D., Ph.D., F.R.C.S., F.R.C.S. (Tr & Orth), M.B.B.S. , Natalie Keough Ph.D., M.Sc. , Rachel M. Frank M.D. , Scott Rodeo M.D.

Purpose

To perform a systematic review of clinical outcomes in patients who underwent treatment with micro-fragmented aspirated tissue for symptoms of knee osteoarthritis.

Methods

Medline, Embase, Scopus, and Google Scholar were screened for studies from 2000 to 2023. Risk of bias (ROB) was assessed using the Cochrane Collaboration’s tools and the Risk Of Bias In Non-randomised Studies-of Interventions tool. Study quality was assessed with the modified Coleman Methodology Score and Methodological Index for Non-Randomized Studies score. Heterogeneity was assessed using χ2 and I2 statistics.

Results

Twenty-one studies were included. One study had a high ROB, 1 had a critical ROB, 3 had serious ROB, and 16 had a moderate ROB. The mean Coleman score was 58, demonstrating fair study quality; the Methodological Index for Non-Randomized Studies score had a mean value of 13, indicating overall fair quality. Best evidence synthesis revealed moderate evidence. The visual analog scale score improved from 5.2 to 3.2 at 6 and 12 months. Knee injury and Osteoarthritis Outcome Score (KOOS) activities of daily living subscore improved from 58.8 to 70.2 at 6 months and 67.5 at 12 months. KOOS pain subscore improved from 54.3 to 70.2 at 6 months and 72.4 at 12 months. KOOS quality of life subscore improved from 33.1 to 43.6 at 6 months and 42.9 at 12 months. KOOS sports subscore improved from 23.7 to 43.6 at 6 months and 57.4 at 12 months. KOOS symptoms subscore improved from 55.3 to 70.1 at 6 months and 67.9 at 12 months. The Western Ontario and McMaster Universities Osteoarthritis Index score steadily increased from 61.8 at baseline to 78.4 at 12 months.

Conclusions

micro-fragmented aspirated tissue injection therapy for the treatment of symptomatic knee osteoarthritis is effective and improves pain and functional outcomes. Moderate study quality combined with a moderate risk of bias, moderate certainty of evidence, and moderate best synthesis evidence reduces external validity. Therefore, the results should be interpreted with a degree of caution.

Level of Evidence

Level IV, systematic review of Level I-IV studies.
目的:对使用微碎屑抽吸脂肪(MFAT)治疗症状患者的临床疗效进行系统回顾:方法:筛选Medline、Embase、Scopus和Google Scholar上2000年至2023年的研究。使用 Cochrane 协作组织的工具和 ROBINS-I 工具评估偏倚风险(ROB)。研究质量采用改良科尔曼方法(CMS)和 MINORS 评分进行评估。使用χ2和I2统计量评估异质性。其中 1 项研究的 ROB 为高,1 项研究的 ROB 为临界,3 项研究的 ROB 为严重,16 项研究的 ROB 为中等。Coleman 评分的平均值为 58 分,表明研究质量尚可;MINORS 评分的平均值为 13 分,表明总体质量尚可。最佳证据综合显示证据中等。在 6 个月和 12 个月时,VAS 评分从 5.2 分提高到 3.2 分。KOOS 分量表 ADL 在 6 个月和 12 个月时分别从 58.8 分和 67.5 分提高到 70.2 分。KOOS 疼痛分量表从 54.3 分提高到 6 个月时的 70.2 分和 12 个月时的 72.4 分。KOOS 分量表 QOL 从 33.1 分提高到 6 个月时的 43.6 分和 12 个月时的 42.9 分。KOOS 运动分量表从 23.7 分提高到 6 个月时的 43.6 分和 12 个月时的 57.4 分。KOOS 分量表中的症状在 6 个月和 12 个月时分别从 55.3 分和 67.9 分提高到 70.1 分。KOOS 疼痛分量表从 54.3 分提高到 6 个月时的 70.2 分和 12 个月时的 72.4 分。WOMAC评分从基线时的61.8分稳步上升至12个月时的78.4分:结论:MFAT注射疗法治疗有症状的膝关节骨性关节炎效果显著,可改善疼痛和功能。中度的研究质量加上中度的偏倚风险、中度的证据确定性和中度的最佳综合证据降低了外部有效性。因此,对结果的解释应持谨慎态度。
{"title":"Micro-Fragmented Adipose Tissue Demonstrates Comparable Clinical Efficacy to Other Orthobiologic Injections in Treating Symptomatic Knee Osteoarthritis: A Systematic Review of Level I to IV Clinical Studies","authors":"Erik Hohmann M.D., Ph.D., F.R.C.S., F.R.C.S. (Tr & Orth), M.B.B.S. ,&nbsp;Natalie Keough Ph.D., M.Sc. ,&nbsp;Rachel M. Frank M.D. ,&nbsp;Scott Rodeo M.D.","doi":"10.1016/j.arthro.2024.03.002","DOIUrl":"10.1016/j.arthro.2024.03.002","url":null,"abstract":"<div><h3>Purpose</h3><div>To perform a systematic review<span> of clinical outcomes in patients who underwent treatment with micro-fragmented aspirated tissue for symptoms of knee osteoarthritis.</span></div></div><div><h3>Methods</h3><div>Medline, Embase, Scopus, and Google Scholar were screened for studies from 2000 to 2023. Risk of bias (ROB) was assessed using the Cochrane Collaboration’s tools and the Risk Of Bias In Non-randomised Studies-of Interventions tool. Study quality was assessed with the modified Coleman Methodology Score and Methodological Index for Non-Randomized Studies score. Heterogeneity was assessed using χ<sup>2</sup> and <em>I</em><sup>2</sup> statistics.</div></div><div><h3>Results</h3><div><span><span><span>Twenty-one studies were included. One study had a high ROB, 1 had a critical ROB, 3 had serious ROB, and 16 had a moderate ROB. The mean Coleman score was 58, demonstrating fair study quality; the Methodological Index for Non-Randomized Studies score had a mean value of 13, indicating overall fair quality. Best evidence synthesis revealed moderate evidence. The visual analog scale score improved from 5.2 to 3.2 at 6 and 12 months. </span>Knee injury and Osteoarthritis Outcome Score<span> (KOOS) activities of daily living subscore improved from 58.8 to 70.2 at 6 months and 67.5 at 12 months. KOOS pain subscore improved from 54.3 to 70.2 at 6 months and 72.4 at 12 months. KOOS </span></span>quality of life subscore improved from 33.1 to 43.6 at 6 months and 42.9 at 12 months. KOOS sports subscore improved from 23.7 to 43.6 at 6 months and 57.4 at 12 months. KOOS symptoms subscore improved from 55.3 to 70.1 at 6 months and 67.9 at 12 months. The </span>Western Ontario and McMaster Universities Osteoarthritis Index score steadily increased from 61.8 at baseline to 78.4 at 12 months.</div></div><div><h3>Conclusions</h3><div>micro-fragmented aspirated tissue injection therapy for the treatment of symptomatic knee osteoarthritis is effective and improves pain and functional outcomes. Moderate study quality combined with a moderate risk of bias, moderate certainty of evidence, and moderate best synthesis evidence reduces external validity. Therefore, the results should be interpreted with a degree of caution.</div></div><div><h3>Level of Evidence</h3><div>Level IV, systematic review of Level I-IV studies.</div></div>","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":"41 2","pages":"Pages 418-441.e14"},"PeriodicalIF":4.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140102917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Commentary: I Used to Be an Under-represented Minority 我曾经是一名少数民族代表(URM)。
IF 4.4 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-02-01 DOI: 10.1016/j.arthro.2024.06.028
Richard K.N. Ryu M.D.
Women and under-represented minorities continue to reflect the lack of diversity in the field of orthopaedic surgery, the cause of which can best be described as multifactorial. That this predicament needs to be remedied is without controversy. How this can be achieved is the bigger question. A top-down approach has been relatively ineffective, and a bolder, more foundational bottom-up approach, in which a “pipeline of talent” is nurtured, may be a solution.
女性和URM(代表人数不足的少数民族)继续反映出骨科领域缺乏多样性,其原因可以用多因素来形容。这种困境需要补救,这一点毫无争议。如何实现这一目标才是更大的问题。自上而下的方法效果相对较差,而更大胆、更具基础性的自下而上的方法,即培养 "人才管道",可能是一种解决方案。
{"title":"Editorial Commentary: I Used to Be an Under-represented Minority","authors":"Richard K.N. Ryu M.D.","doi":"10.1016/j.arthro.2024.06.028","DOIUrl":"10.1016/j.arthro.2024.06.028","url":null,"abstract":"<div><div>Women and under-represented minorities continue to reflect the lack of diversity in the field of orthopaedic surgery, the cause of which can best be described as multifactorial. That this predicament needs to be remedied is without controversy. How this can be achieved is the bigger question. A top-down approach has been relatively ineffective, and a bolder, more foundational bottom-up approach, in which a “pipeline of talent” is nurtured, may be a solution.</div></div>","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":"41 2","pages":"Pages 286-288"},"PeriodicalIF":4.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141472918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Podium Presentation Title: Comparison of Clinical Outcomes and Return to Sport Rates Between Osteochondral Allograft Transplantation and Autologous Chondrocyte Implantation for Articular Cartilage Lesions in the Patellofemoral Joint
IF 4.4 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-02-01 DOI: 10.1016/j.arthro.2024.11.021
Jairo Triana B.S., Andrew Hughes F.R.C.S., Naina Rao B.S., Zachary Li B.A., Michael Moore B.A., Sharif Garra M.D., Eric Strauss M.D., Kirk Campbell M.D., Guillem Gonzalez-Lomas M.D.
{"title":"Podium Presentation Title: Comparison of Clinical Outcomes and Return to Sport Rates Between Osteochondral Allograft Transplantation and Autologous Chondrocyte Implantation for Articular Cartilage Lesions in the Patellofemoral Joint","authors":"Jairo Triana B.S.,&nbsp;Andrew Hughes F.R.C.S.,&nbsp;Naina Rao B.S.,&nbsp;Zachary Li B.A.,&nbsp;Michael Moore B.A.,&nbsp;Sharif Garra M.D.,&nbsp;Eric Strauss M.D.,&nbsp;Kirk Campbell M.D.,&nbsp;Guillem Gonzalez-Lomas M.D.","doi":"10.1016/j.arthro.2024.11.021","DOIUrl":"10.1016/j.arthro.2024.11.021","url":null,"abstract":"","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":"41 2","pages":"Pages e8-e9"},"PeriodicalIF":4.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143129050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hyaluronate Acid Plus Platelet-Rich Plasma Is Superior to Steroids for Pain Relief Less Than 6 Months Using Injection Therapy of Partial Rotator Cuff Tears: A Systematic Review and Network Meta-analysis 使用注射疗法治疗部分肩袖撕裂后 6 个月以内的疼痛缓解效果,透明质酸加血小板丰富血浆优于类固醇:系统综述和网络荟萃分析。
IF 4.4 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-02-01 DOI: 10.1016/j.arthro.2024.03.035
Viktor Weninger M.D. , Gergely Agócs Ph.D. , Norbert Kovács M.D. , Szilárd Váncsa M.D. , Luca Hergár M.D. , Chan Ju Baek , Péter Hegyi M.D., DSc. , Gergely Holnapy Ph.D. , Gábor Skaliczki M.D., Ph.D.

Purpose

To compare the efficacy of steroid injections to other injectable therapies in partial-thickness rotator cuff (RC) tears.

Methods

A systematic literature search was performed until October 25, 2021, in 3 databases (Cochrane Central Register of Controlled Trials, Embase, MEDLINE). Eligible studies compared the efficacy of steroid, hyaluronic acid (HA), platelet-rich plasma (PRP), the combination of HA and PRP (HA + PRP), and adipose-derived regenerative cells in RC tears. The primary outcomes were the visual analog scale (VAS), Constant-Murley Shoulder Outcome Score (CMS) and American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form. Using paired and network meta-analysis, we calculated pooled mean differences (MDs) with 95% confidence intervals (CIs).

Results

We included a total of 7 articles in the quantitative synthesis. In shorter periods, the HA + PRP combination was superior to the other substances we investigated (HA + PRP: VAS [0-4 weeks]: MD: −0.99 [95% CI, −1.62 to −0.36]; CMS [0-3 months]: 20.56 [95% CI, 16.18 to 24.94]. This combination was followed by the use of HA or PRP alone, depending on the duration of follow-up and the outcome being studied. In our study, short-term results suggest that saline is superior to steroids for partial tears, but this trend is reversed at 6-month follow-up.

Conclusions

The HA and PRP combination is currently the most effective in partial RC tear treatment in the short term. After 6 months, there is no meaningful difference, so the benefits of the combination are short term.

Level of Evidence

Level II, systematic review and meta-analysis of Level I and II studies.
目的:我们进行了网络荟萃分析,比较类固醇注射与其他注射疗法对部分厚度肩袖撕裂(PTRCTs)的疗效:在三个数据库(CENTRAL、Embase、MEDLINE)中进行了系统性文献检索,截止日期为 2021 年 10 月 25 日。符合条件的研究比较了类固醇、透明质酸(HA)、富血小板血浆(PRP)、HA 和 PRP 组合(HA+PRP)以及脂肪源性再生细胞(ADRC)对 RC 撕裂的疗效。主要研究结果为视觉模拟量表(VAS)、恒定默利评分(CMS)和美国肩肘外科医生标准化肩关节评估表。通过配对分析和网络荟萃分析,我们计算了汇总的平均差异(MDs)和 95% 的置信区间(CIs):结果:我们共纳入了七篇文章进行定量综合分析。在较短时间内,HA+PRP 组合优于我们研究的其他物质(HA+PRP:VAS(0-4 周):MD:-0.99 [CI = -1.62, -0.36];CMS(0-3 个月):20.56 [CI = 16.18, 24.94]。根据随访时间的长短和研究结果的不同,这种组合之后是单独使用 HA 或 PRP。在我们的研究中,短期结果表明生理盐水治疗部分撕裂优于类固醇,但这种趋势在随访六个月后发生逆转:结论:我们的研究结果表明,在短期内,HA 和 PRP 的组合对部分 RC 破裂是一种更有效的治疗选择,但在 6 个月后并无显著差异:II级,包括I-II级证据研究。
{"title":"Hyaluronate Acid Plus Platelet-Rich Plasma Is Superior to Steroids for Pain Relief Less Than 6 Months Using Injection Therapy of Partial Rotator Cuff Tears: A Systematic Review and Network Meta-analysis","authors":"Viktor Weninger M.D. ,&nbsp;Gergely Agócs Ph.D. ,&nbsp;Norbert Kovács M.D. ,&nbsp;Szilárd Váncsa M.D. ,&nbsp;Luca Hergár M.D. ,&nbsp;Chan Ju Baek ,&nbsp;Péter Hegyi M.D., DSc. ,&nbsp;Gergely Holnapy Ph.D. ,&nbsp;Gábor Skaliczki M.D., Ph.D.","doi":"10.1016/j.arthro.2024.03.035","DOIUrl":"10.1016/j.arthro.2024.03.035","url":null,"abstract":"<div><h3>Purpose</h3><div>To compare the efficacy of steroid injections to other injectable therapies in partial-thickness rotator cuff (RC) tears.</div></div><div><h3>Methods</h3><div>A systematic literature search was performed until October 25, 2021, in 3 databases (Cochrane Central Register of Controlled Trials, Embase, MEDLINE). Eligible studies compared the efficacy of steroid, hyaluronic acid (HA), platelet-rich plasma (PRP), the combination of HA and PRP (HA + PRP), and adipose-derived regenerative cells in RC tears. The primary outcomes were the visual analog scale (VAS), Constant-Murley Shoulder Outcome Score (CMS) and American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form. Using paired and network meta-analysis, we calculated pooled mean differences (MDs) with 95% confidence intervals (CIs).</div></div><div><h3>Results</h3><div>We included a total of 7 articles in the quantitative synthesis. In shorter periods, the HA + PRP combination was superior to the other substances we investigated (HA + PRP: VAS [0-4 weeks]: MD: −0.99 [95% CI, −1.62 to −0.36]; CMS [0-3 months]: 20.56 [95% CI, 16.18 to 24.94]. This combination was followed by the use of HA or PRP alone, depending on the duration of follow-up and the outcome being studied. In our study, short-term results suggest that saline is superior to steroids for partial tears, but this trend is reversed at 6-month follow-up.</div></div><div><h3>Conclusions</h3><div>The HA and PRP combination is currently the most effective in partial RC tear treatment in the short term. After 6 months, there is no meaningful difference, so the benefits of the combination are short term.</div></div><div><h3>Level of Evidence</h3><div>Level II, systematic review and meta-analysis of Level I and II studies.</div></div>","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":"41 2","pages":"Pages 304-315"},"PeriodicalIF":4.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Posterior Shoulder Instability, Part I—Diagnosis, Nonoperative Management, and Labral Repair for Posterior Shoulder Instability—An International Expert Delphi Consensus Statement 肩关节后方失稳第一部分--肩关节后方失稳的诊断、非手术治疗和韧带修复--国际专家德尔菲共识声明。
IF 4.4 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-02-01 DOI: 10.1016/j.arthro.2024.04.035
Eoghan T. Hurley M.D., Ph.D. , Zachary S. Aman M.D. , Tom R. Doyle M.B., M.Ch. , Jay M. Levin M.D., M.B.A. , Laith M. Jazrawi M.D. , Grant E. Garrigues M.D. , Surena Namdari M.D. , Jason E. Hsu M.D. , Christopher S. Klifto M.D. , Oke Anakwenze M.D., M.B.A. , Jonathan F. Dickens M.D.

Purpose

To establish consensus statements on the diagnosis, nonoperative management, and labral repair for posterior shoulder instability.

Methods

A consensus process on the treatment of posterior shoulder instability was conducted, with 71 shoulder/sports surgeons from 12 countries participating on the basis of their level of expertise in the field. Experts were assigned to 1 of 6 working groups defined by specific subtopics within posterior shoulder instability. Consensus was defined as achieving 80% to 89% agreement, whereas strong consensus was defined as 90% to 99% agreement, and unanimous consensus was indicated by 100% agreement with a proposed statement.

Results

Unanimous agreement was reached on the indications for nonoperative management and labral repair, which include whether patients had primary or recurrent instability, with symptoms/functional limitations, and whether there was other underlying pathology, or patient’s preference to avoid or delay surgery. In addition, there was unanimous agreement that recurrence rates can be diminished by attention to detail, appropriate indication and assessment of risk factors, recognition of abnormalities in glenohumeral morphology, careful capsulolabral debridement and reattachment, small anchors with inferior placement and multiple fixation points that create a bumper with the labrum, treatment of concomitant pathologies, and a well-defined rehabilitation protocol with strict postoperative immobilization.

Conclusions

The study group achieved strong or unanimous consensus on 63% of statements related to the diagnosis, nonoperative treatment, and labrum repair for posterior shoulder instability. The statements that achieved unanimous consensus were the relative indications for nonoperative management, and the relative indications for labral repair, as well as the steps to minimize complications for labral repair. There was no consensus on whether an arthrogram is needed when performing advanced imaging, the role of corticosteroids/orthobiologics in nonoperative management, whether a posteroinferior portal is required.

Level of Evidence

Level V, expert opinion.
目的:本研究旨在就肩关节后方不稳定的诊断、非手术治疗和唇瓣修复达成共识:方法:根据来自 12 个国家的 71 名肩关节/运动外科医生在该领域的专业水平,就肩关节后方不稳的治疗方法达成了共识。专家们被分配到 6 个工作组中的一个,这 6 个工作组是根据肩关节后方不稳定的特定子课题定义的。共识的定义是达成 80-89% 的一致意见,强烈共识的定义是达成 90-99% 的一致意见,而一致共识则是对某项建议声明达成 100% 的一致意见:就非手术治疗和唇瓣修复的适应症达成了一致意见,其中包括患者是否存在原发性或复发性不稳定,是否有症状/功能受限,是否存在其他潜在病变,或患者是否愿意避免或推迟手术。此外,研究小组还一致认为,关注细节、适当的适应症和风险因素评估、识别盂肱形态异常、仔细进行髋臼囊清创和重新连接、下置小锚和多个固定点以与髋臼唇形成缓冲、治疗并发病症以及术后严格固定的定义明确的康复方案可降低复发率:研究小组就63%的肩关节后方不稳的诊断、非手术治疗和盂唇修复相关声明达成了强烈或一致的共识。达成一致共识的声明包括非手术治疗的相对适应症、肩关节唇修复的相对适应症以及将肩关节唇修复并发症降至最低的步骤。对于在进行高级成像时是否需要关节造影、皮质类固醇/生物制剂在非手术治疗中的作用、是否需要后内侧入口等问题,与会者未达成共识。
{"title":"Posterior Shoulder Instability, Part I—Diagnosis, Nonoperative Management, and Labral Repair for Posterior Shoulder Instability—An International Expert Delphi Consensus Statement","authors":"Eoghan T. Hurley M.D., Ph.D. ,&nbsp;Zachary S. Aman M.D. ,&nbsp;Tom R. Doyle M.B., M.Ch. ,&nbsp;Jay M. Levin M.D., M.B.A. ,&nbsp;Laith M. Jazrawi M.D. ,&nbsp;Grant E. Garrigues M.D. ,&nbsp;Surena Namdari M.D. ,&nbsp;Jason E. Hsu M.D. ,&nbsp;Christopher S. Klifto M.D. ,&nbsp;Oke Anakwenze M.D., M.B.A. ,&nbsp;Jonathan F. Dickens M.D.","doi":"10.1016/j.arthro.2024.04.035","DOIUrl":"10.1016/j.arthro.2024.04.035","url":null,"abstract":"<div><h3>Purpose</h3><div>To establish consensus statements on the diagnosis, nonoperative management, and labral repair for posterior shoulder instability.</div></div><div><h3>Methods</h3><div>A consensus process on the treatment of posterior shoulder instability was conducted, with 71 shoulder/sports surgeons from 12 countries participating on the basis of their level of expertise in the field. Experts were assigned to 1 of 6 working groups defined by specific subtopics within posterior shoulder instability. Consensus was defined as achieving 80% to 89% agreement, whereas strong consensus was defined as 90% to 99% agreement, and unanimous consensus was indicated by 100% agreement with a proposed statement.</div></div><div><h3>Results</h3><div>Unanimous agreement was reached on the indications for nonoperative management and labral repair, which include whether patients had primary or recurrent instability, with symptoms/functional limitations, and whether there was other underlying pathology, or patient’s preference to avoid or delay surgery. In addition, there was unanimous agreement that recurrence rates can be diminished by attention to detail, appropriate indication and assessment of risk factors, recognition of abnormalities in glenohumeral morphology, careful capsulolabral debridement and reattachment, small anchors with inferior placement and multiple fixation points that create a bumper with the labrum, treatment of concomitant pathologies, and a well-defined rehabilitation protocol with strict postoperative immobilization.</div></div><div><h3>Conclusions</h3><div>The study group achieved strong or unanimous consensus on 63% of statements related to the diagnosis, nonoperative treatment, and labrum repair for posterior shoulder instability. The statements that achieved unanimous consensus were the relative indications for nonoperative management, and the relative indications for labral repair, as well as the steps to minimize complications for labral repair. There was no consensus on whether an arthrogram is needed when performing advanced imaging, the role of corticosteroids/orthobiologics in nonoperative management, whether a posteroinferior portal is required.</div></div><div><h3>Level of Evidence</h3><div>Level V, expert opinion.</div></div>","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":"41 2","pages":"Pages 166-180.e11"},"PeriodicalIF":4.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140912731","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microfragmented Adipose Tissue Injection Reduced Pain Compared With a Saline Control Among Patients With Symptomatic Osteoarthritis of the Knee During 1-Year Follow-Up: A Randomized Controlled Trial 与生理盐水对照组相比,微碎屑脂肪组织注射液可在一年的随访期间减轻无症状膝骨关节炎患者的疼痛:一项随机对照试验。
IF 4.4 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-02-01 DOI: 10.1016/j.arthro.2024.08.037
Dustin L. Richter M.D. , Joshua L. Harrison M.D. , Lauren Faber M.D. , Samuel Schrader M.D. , Yiliang Zhu Ph.D. , Carina Pierce , Leorrie Watson , Anil K. Shetty M.D. , Robert C. Schenck Jr. M.D.

Purpose

To evaluate the effectiveness of microfragmented adipose tissue (MFAT) for pain relief and improved joint functionality in osteoarthritis (OA) of the knee in a randomized controlled clinical trial with 1-year follow-up.

Methods

Seventy-five patients were stratified by baseline pain level and randomized to 1 of 3 treatment groups: MFAT, corticosteroid (CS), or saline control (C) injection. Patients 18 years of age or older, diagnosed with symptomatic OA of the knee, with radiographic evidence of OA of the knee and a visual analog pain scale score of 3 of 10 or greater were included. Patients were excluded if they had any previous intra-articular knee injection, current knee ligamentous instability, or an allergy to lidocaine/corticosteroid. The visual analog pain scale, Western Ontario and McMaster Universities Osteoarthritis Index, and the Knee Injury and Osteoarthritis Outcome score (KOOS) were recorded preprocedure and at 2 weeks, 6 weeks, 3 and 6 months, and 1-year follow-up.

Results

MFAT demonstrated consistent and statistically significant improvements across all primary outcome measures for joint pain and functionality compared with C. For MFAT, there was a significant improvement over baseline at each follow-up, with median (95% confidence interval) KOOS Pain score changes of 18.1 (11.1-26.4) at week 2 to 27.8 (19.4-37.5) at 1 year. For CS, the median KOOS pain score reached a maximum of 22.2 (15.3-30.6) at week 2, only to level off to 13.9 (–2.8 to 29.2), a level not statistically different from baseline, at 1 year. The median changes for C hovered around 6 to 11 points, with statistically significant improvements over baseline indicating a placebo effect. Similar trends were seen for the Western Ontario and McMaster Universities Osteoarthritis Index Pain score and VAS Pain score.

Conclusions

In this study, MFAT demonstrated a clinically significant improvement in primary outcome scores compared with the C group, whereas the CS group only showed statistically significant improvement compared with the C group at 2 and 6 weeks. This finding indicates that MFAT may be a viable alternative treatment for patients with OA of the knee who fall into the orthopaedic treatment gap.

Level of Evidence

Level II, partially blinded, randomized controlled clinical trial.
目的:在一项为期 1 年的随机对照临床试验中,评估微碎屑脂肪组织(MFAT)在缓解膝关节 OA 疼痛和改善关节功能方面的效果:根据基线疼痛程度对 75 名患者进行分层,并随机分为三个治疗组:注射 MFAT、皮质类固醇 (CS) 或生理盐水对照 (C)。患者年龄在 18 岁或以上,确诊为无症状膝关节骨性关节炎,膝关节骨性关节炎有放射学证据,视觉模拟疼痛量表(VAS)评分在 3/10 或以上。曾进行过膝关节内注射、目前膝关节韧带不稳定或对利多卡因/皮质类固醇过敏的患者除外。术前、2周、6周、3个月和6个月以及1年的随访中记录了VAS疼痛量表、西安大略和麦克马斯特大学骨关节炎指数(WOMAC)以及膝关节损伤和骨关节炎结果评分(KOOS):MFAT与C相比,在关节疼痛和功能方面的所有主要结果指标上都有一致且具有统计学意义的改善。对于MFAT,每次随访都比基线有显著改善,KOOS疼痛评分的中位数(95% CI)变化从第2周的18.1(11.1,26.4)到1年时的27.8(19.4,37.5)。对于 CS,KOOS 疼痛评分的中位数在第 2 周达到最高值 22.2(15.3,30.6),但在 1 年后降至 13.9(-2.8,29.2),与基线无统计学差异。C 的中位变化徘徊在 6-11 点之间,与基线相比有统计学意义的显著改善表明存在安慰剂效应。WOMAC疼痛评分和VAS疼痛评分也有类似趋势:在这项研究中,与生理盐水对照组相比,MFAT 在主要结果评分方面有显著的临床改善,而与对照组相比,皮质类固醇组仅在 2 周和 6 周时有统计学意义上的显著改善。这一结果表明,MFAT 可能是骨科治疗空白领域膝关节 OA 患者的一种可行的替代治疗方法。
{"title":"Microfragmented Adipose Tissue Injection Reduced Pain Compared With a Saline Control Among Patients With Symptomatic Osteoarthritis of the Knee During 1-Year Follow-Up: A Randomized Controlled Trial","authors":"Dustin L. Richter M.D. ,&nbsp;Joshua L. Harrison M.D. ,&nbsp;Lauren Faber M.D. ,&nbsp;Samuel Schrader M.D. ,&nbsp;Yiliang Zhu Ph.D. ,&nbsp;Carina Pierce ,&nbsp;Leorrie Watson ,&nbsp;Anil K. Shetty M.D. ,&nbsp;Robert C. Schenck Jr. M.D.","doi":"10.1016/j.arthro.2024.08.037","DOIUrl":"10.1016/j.arthro.2024.08.037","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the effectiveness of microfragmented adipose tissue (MFAT) for pain relief and improved joint functionality in osteoarthritis (OA) of the knee in a randomized controlled clinical trial with 1-year follow-up.</div></div><div><h3>Methods</h3><div>Seventy-five patients were stratified by baseline pain level and randomized to 1 of 3 treatment groups: MFAT, corticosteroid (CS), or saline control (C) injection. Patients 18 years of age or older, diagnosed with symptomatic OA of the knee, with radiographic evidence of OA of the knee and a visual analog pain scale score of 3 of 10 or greater were included. Patients were excluded if they had any previous intra-articular knee injection, current knee ligamentous instability, or an allergy to lidocaine/corticosteroid. The visual analog pain scale, Western Ontario and McMaster Universities Osteoarthritis Index, and the Knee Injury and Osteoarthritis Outcome score (KOOS) were recorded preprocedure and at 2 weeks, 6 weeks, 3 and 6 months, and 1-year follow-up.</div></div><div><h3>Results</h3><div>MFAT demonstrated consistent and statistically significant improvements across all primary outcome measures for joint pain and functionality compared with C. For MFAT, there was a significant improvement over baseline at each follow-up, with median (95% confidence interval) KOOS Pain score changes of 18.1 (11.1-26.4) at week 2 to 27.8 (19.4-37.5) at 1 year. For CS, the median KOOS pain score reached a maximum of 22.2 (15.3-30.6) at week 2, only to level off to 13.9 (–2.8 to 29.2), a level not statistically different from baseline, at 1 year. The median changes for C hovered around 6 to 11 points, with statistically significant improvements over baseline indicating a placebo effect. Similar trends were seen for the Western Ontario and McMaster Universities Osteoarthritis Index Pain score and VAS Pain score.</div></div><div><h3>Conclusions</h3><div>In this study, MFAT demonstrated a clinically significant improvement in primary outcome scores compared with the C group, whereas the CS group only showed statistically significant improvement compared with the C group at 2 and 6 weeks. This finding indicates that MFAT may be a viable alternative treatment for patients with OA of the knee who fall into the orthopaedic treatment gap.</div></div><div><h3>Level of Evidence</h3><div>Level II, partially blinded, randomized controlled clinical trial.</div></div>","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":"41 2","pages":"Pages 248-260"},"PeriodicalIF":4.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142146955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial Commentary: Off-the-Shelf Large Language Models Are of Insufficient Quality to Provide Medical Treatment Recommendations, While Customization of Large Language Models Results in Quality Recommendations 现成的大语言模型(LLM)质量不高,无法提供医疗建议,而定制 LLM 可提供高质量的建议。
IF 4.4 1区 医学 Q1 ORTHOPEDICS Pub Date : 2025-02-01 DOI: 10.1016/j.arthro.2024.09.047
Prem N. Ramkumar M.D., M.B.A. (Associate Editor), Andrew F. Masotto B.S., Joshua J. Woo B.A.
The content accuracy of off-the-shelf large language models (LLMs) mirrors the content accuracy of the unregulated Internet from which these generative artificial intelligence models are supplied. With error rates approximating 30% in terms of treatment recommendations for the management of common musculoskeletal conditions, seeking expert opinion remains paramount. However, custom LLMs represent an excellent opportunity to infuse niche, bespoke expertise from the many specialties and subspecialties within medicine. Methods of customizing these generative models broadly fall under the categories of prompt engineering; “retrieval-augmented generation” prioritizing retrieval of relevant information from a specific domain of data; “fine-tuning” of a basic pretrained model into one that is refined for health care–related vernacular and acronyms; and “agentic augmentation” including software that breaks down complex tasks into smaller ones, recruiting multiple LLMs (with or without retrieval-augmented generation), optimizing the output, internally deciding whether the response is appropriate or sufficient, and even passing on an unmet outcome to a human for supervision (“phone a friend”). Custom LLMs offer physicians and their associated organizations the rare opportunity to regain control of our profession by re-establishing authority in our increasingly digital landscape.
现成的 LLM 的内容准确性反映了无监管互联网的内容准确性,而这些生成式人工智能模型正是由互联网提供的。在常见肌肉骨骼疾病的治疗建议方面,错误率约为 30%,因此寻求专家意见仍然至关重要。然而,定制的 LLM 是一个绝佳的机会,可以从医学的许多专科和亚专科中注入利基、定制的专业知识。定制这些生成模型的方法大致可分为以下几类:提示工程、优先从特定数据领域检索相关信息的 "检索增强生成"(RAG)、将基本的预训练模型 "微调 "为针对医疗保健相关术语和缩略语进行细化的模型,以及 "代理增强"(agentic augmentation)、以及 "代理增强",包括将复杂任务分解成更小任务的软件、招募多个 LLM(有或没有 RAG)、优化输出、内部决定响应是否适当或充分,甚至将未满足的结果转给人工进行监督("打电话给朋友")。定制 LLM 为医生及其相关组织提供了一个难得的机会,在日益数字化的环境中重新树立权威,从而重新掌控我们的职业。
{"title":"Editorial Commentary: Off-the-Shelf Large Language Models Are of Insufficient Quality to Provide Medical Treatment Recommendations, While Customization of Large Language Models Results in Quality Recommendations","authors":"Prem N. Ramkumar M.D., M.B.A. (Associate Editor),&nbsp;Andrew F. Masotto B.S.,&nbsp;Joshua J. Woo B.A.","doi":"10.1016/j.arthro.2024.09.047","DOIUrl":"10.1016/j.arthro.2024.09.047","url":null,"abstract":"<div><div>The content accuracy of off-the-shelf large language models (LLMs) mirrors the content accuracy of the unregulated Internet from which these generative artificial intelligence models are supplied. With error rates approximating 30% in terms of treatment recommendations for the management of common musculoskeletal conditions, seeking expert opinion remains paramount. However, custom LLMs represent an excellent opportunity to infuse niche, bespoke expertise from the many specialties and subspecialties within medicine. Methods of customizing these generative models broadly fall under the categories of prompt engineering; “retrieval-augmented generation” prioritizing retrieval of relevant information from a specific domain of data; “fine-tuning” of a basic pretrained model into one that is refined for health care–related vernacular and acronyms; and “agentic augmentation” including software that breaks down complex tasks into smaller ones, recruiting multiple LLMs (with or without retrieval-augmented generation), optimizing the output, internally deciding whether the response is appropriate or sufficient, and even passing on an unmet outcome to a human for supervision (“phone a friend”). Custom LLMs offer physicians and their associated organizations the rare opportunity to regain control of our profession by re-establishing authority in our increasingly digital landscape.</div></div>","PeriodicalId":55459,"journal":{"name":"Arthroscopy-The Journal of Arthroscopic and Related Surgery","volume":"41 2","pages":"Pages 276-278"},"PeriodicalIF":4.4,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142378570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arthroscopy-The Journal of Arthroscopic and Related Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1